PRESS RELEASE published on 07/25/2024 at 14:01, 1 year 9 months ago Mainz Biomed Launches Enhanced ColoAlert with Cutting-Edge Features to Optimize Screening Efficiency and User Convenience Mainz Biomed launches enhanced ColoAlert test with new features to improve screening efficiency and user experience. The updates aim to optimize colorectal cancer detection ColoAlert Mainz Biomed Colorectal Cancer Screening Efficiency Enhanced Test
BRIEF published on 07/09/2024 at 09:06, 1 year 10 months ago Mainz Biomed Submits for FDA Breakthrough Device Designation for CRC Screening Test Mainz Biomed Colorectal Cancer FDA Submission Breakthrough Device Screening Test
BRIEF published on 07/09/2024 at 09:06, 1 year 10 months ago Mainz Biomed soumet une demande de désignation de dispositif révolutionnaire par la FDA pour le test de dépistage du CRC Cancer Colorectal Mayence Biomed Soumission À La FDA Appareil Révolutionnaire Test De Dépistage
PRESS RELEASE published on 07/09/2024 at 09:01, 1 year 10 months ago Mainz Biomed Announces Submission for FDA Breakthrough Device Designation for its Next Generation CRC Screening Test Mainz Biomed N.V. seeks FDA Breakthrough Device Designation for Next Generation CRC Screening Test with impressive clinical results Mainz Biomed N.V. Colorectal Cancer MRNA Biomarkers FDA Breakthrough Device Designation Next Generation CRC Screening Test
BRIEF published on 07/02/2024 at 14:06, 1 year 10 months ago Mainz Biomed Provides Half Year 2024 Corporate Update Diagnostic Solutions FDA Approval Mainz Biomed Colorectal Cancer Half Year Results
BRIEF published on 07/02/2024 at 14:06, 1 year 10 months ago Mainz Biomed fournit une mise à jour d'entreprise pour le semestre 2024 Résultats Semestriels Cancer Colorectal Mayence Biomed Approbation De La FDA Solutions De Diagnostic
PRESS RELEASE published on 07/02/2024 at 14:01, 1 year 10 months ago Mainz Biomed Provides Half Year 2024 Corporate Update Mainz Biomed N.V. provides corporate update for the first half of 2024, showcasing industry-leading clinical data and strategic partnerships. Expect half-year financial results in September 2024 Strategic Partnerships Corporate Update Clinical Data Mainz Biomed N.V. Half-year Financial Results
BRIEF published on 06/03/2024 at 14:06, 1 year 11 months ago Mainz Biomed Unveils Industry-Leading Study Results at ASCO 2024 Mainz Biomed MRNA Biomarkers ASCO 2024 CRC Detection Multimodal Screening
BRIEF published on 06/03/2024 at 14:06, 1 year 11 months ago Mainz Biomed dévoile les résultats d'une étude de pointe à l'ASCO 2024 Mayence Biomed Biomarqueurs D'ARNm ASCO 2024 Détection CRC Dépistage Multimodal
PRESS RELEASE published on 06/03/2024 at 14:01, 1 year 11 months ago Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024 Mainz Biomed presented industry-leading results of its pooled study at ASCO 2024, demonstrating high sensitivity in detecting colorectal cancer and precancerous lesions using mRNA biomarkers and AI algorithm Mainz Biomed Colorectal Cancer MRNA Biomarkers ASCO 2024 Precancerous Lesions
Published on 05/14/2026 at 03:15, 53 minutes ago Jaguar Delivers Strong Adjusted Earnings and Strategic Production Restart of MTL (Turmalina Mine) in Q1 2026
Published on 05/13/2026 at 23:30, 4 hours 38 minutes ago CCL Industries Announces Results for 2026 First Quarter
Published on 05/13/2026 at 23:15, 4 hours 53 minutes ago Avino Delivers Record Q1 2026 Financial Results
Published on 05/14/2026 at 03:20, 48 minutes ago TCL Electronics (01070.HK) Maintains Strong Growth in Q1 2026
Published on 05/14/2026 at 01:05, 3 hours 3 minutes ago THE ROYAL MINT SHINES A LIGHT ON PINK FLOYD WITH FIRST EVER UK COMMEMORATIVE COIN
Published on 05/13/2026 at 22:20, 5 hours 47 minutes ago Rumble Announces Initial Results of Exchange Offer for Northern Data
Published on 05/13/2026 at 20:18, 7 hours 50 minutes ago EQS-Adhoc: Northern Data Group Q1 2026 – Above the Preliminary Ranges Communicated on 8 April 2026
Published on 05/13/2026 at 18:02, 10 hours 6 minutes ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
Published on 05/13/2026 at 18:00, 10 hours 8 minutes ago ALTAREIT - Assemblée Générale Mixte du 4 juin 2026 - Modalités de mise à disposition des documents préparatoires
Published on 05/13/2026 at 17:45, 10 hours 23 minutes ago Infotel confirms its return to growth in Q1 2026 with revenue up 8.6%. Proposed dividend of €2 per share for 2025.